Anheuser-Busch InBev (92PF) - Publication of Supplementary Prospectus RNS Number : 3516Q Anheuser-Busch InBev SA/NV 05 November 2012 RNS PUBLICATION FORM Publication of Supplementary Prospectus The following supplementary prospectus has been approved by the UK Listing Authority and is available for viewing: Supplementary prospectus dated 5 November 2012 (the "Supplementary Prospectus"), supplementary to the base prospectus dated 16 May 2012 as previously supplemented by a supplementary prospectus dated 16 August 2012, relating to the €15,000,000,000 Euro Medium Term Note Programme of Brandbrew S.A. and Anheuser-Busch InBev SA/NV (the "Prospectus"). To view the Supplementary Prospectus please paste the following URL into the address bar of your browser: http://www.rns-pdf.londonstockexchange.com/rns/3516Q_-2012-11-5.pdf To view the Form 6-K incorporating Anheuser-Busch InBev's Unaudited Interim Report for the 9 month period ended 30 September 2012 as filed with the United States Securities Exchange Commission on 31 October 2012 (the "2012 Nine Month Results"), which is incorporated by reference into the Supplementary Prospectus, please paste the following URL into the address bar of your browser: http://www.rns-pdf.londonstockexchange.com/rns/3516Q_1-2012-11-5.pdf The Supplementary Prospectus and the 2012 Nine Month Results have each been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.Hemscott.com/nsm.do For further information, please contact Benoit Loore or Ann Randon Email: Benoit.Loore@ab-inbev.com, Ann.Randon@ab-inbev.com Anheuser-Busch InBev SA/NV Brouwerijplein 1 3000 Leuven Belgium DISCLAIMER - INTENDED ADDRESSEES Please note that the information contained in the Supplementary Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Supplementary Prospectus is not addressed. Prior to relying on the information contained in the Supplementary Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein. Your right to access this service is conditional upon complying with the above requirement. This information is provided by RNS The company news service from the London Stock Exchange END PDIEALFSEEXAFFF -0- Nov/05/2012 14:10 GMT
Glaxo to Pay $488.7 Million Fine to End China Corruption Probe
Anheuser-Busch InBev 92PF Publication of Supplementary Prospectus
Press spacebar to pause and continue. Press esc to stop.